- CzeekV インデックス

検索結果

- Evaluating the efficacy, safety, and immunogenicity of FDA-approved RSV vaccines: a systematic review of Arexvy, Abrysvo, and mResvia.
  タグ:
  
  VAERS
  
  FAERS
  2025/9/3
- Pharmacovigilance-based 12-year post-marketing safety analysis of quadrivalent influenza vaccines in children: a VAERS surveillance study.
  タグ:
  
  VAERS
  
  FAERS
  2025/9/18
- Characterizing the FDA Adverse Event Reporting System (FAERS) as a Network to Improve Pattern Discovery.
  タグ:
  
  VAERS
  
  FAERS
  2025/9/16
- No disproportionate reporting of inflammatory arthritis following COVID-19 vaccination: a pharmacovigilance study using VAERS data.
  タグ:
  
  VAERS
  
  FAERS
  2025/9/13
- Post-marketing safety surveillance of pneumococcal vaccines: a real-world pharmacovigilance study using the U.S. vaccine adverse event reporting system (VAERS) database.
  タグ:
  
  FAERS
  
  VAERS
  2025/9/11
- Safety monitoring of Pfizer’s Respiratory Syncytial Virus Vaccine in pregnant women in the Vaccine Adverse Event Reporting System (VAERS), 2023-2024, United States.
  タグ:
  
  VAERS
  
  FAERS
  2025/8/3
- Post-marketing safety monitoring of RSV vaccines: A real-world study based on the Vaccine Adverse Event Reporting System (VAERS).
  タグ:
  
  VAERS
  
  FAERS
  2025/8/29
- Real-world safety of herpes zoster vaccines: A pharmacovigilance study based on the vaccine adverse event reporting system (may 2006-december 2024).
  タグ:
  
  VAERS
  
  FAERS
  2025/8/21
- Real-world safety of HPV vaccines over 18 y: A comprehensive analysis of U.S. VAERS reports.
  タグ:
  
  VAERS
  
  FAERS
  2025/8/1
- National Pharmacovigilance Assessment of Oral Adverse Events Following COVID-19 Vaccination in Germany (2020-2023).
  タグ:
  
  VAERS
  
  FAERS
  2025/7/21
- 1
- 2
- ...
- 60
- >

お問合わせ

お問合わせ

検索

サイト内検索・論文検索

メルマガ登録

購読申し込み

Copyright © Ark Medical Solutions Inc. All Rights Reserved.